Technology behind commercial devices for blood glucose monitoring in diabetes management: A review
2011 · Analytica Chimica Acta · 210 citations
https://doi.org/10.1016/j.aca.2011.07.024
K
Khalid Al‐Rubeaan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
6.6K
Citations
44
h-index
86
i10-index
Khalid Al‐Rubeaan is an academic researcher from King Abdulaziz City for Science and Technology. The author has contributed to research in topics: Diabetes, Cardiovascular Risks, and Lipoproteins & Diabetes Management and Research & Diabetes Treatment and Management. The author has an h-index of 44, co-authored 112 publications.
ORCID: 0000-0003-3615-7192Papers by this author
worksResidual macrovascular risk in 2013: what have we learned?
2014 · Cardiovascular Diabetology · 169 citations
https://doi.org/10.1186/1475-2840-13-26
Overweight and Obesity in Saudi Arabian Adult Population, Role of Sociodemographic Variables
1997 · Journal of Community Health · 113 citations
https://doi.org/10.1023/a:1025177108996
Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population
2005 · Cardiovascular Diabetology · 81 citations
https://doi.org/10.1186/1475-2840-4-10
Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population
2008 · BMC Medical Genetics · 75 citations
https://doi.org/10.1186/1471-2350-9-72
Health care services provided to type 1 and type 2 diabetic patients in Saudi Arabia
2015 · Saudi Medical Journal · 25 citations
https://doi.org/10.15537/smj.2015.10.12596
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat